Evaluation of multicomponent recombinant vaccines against Actinobacillus pleuropneumoniae in mice
Open Access
- 11 September 2010
- journal article
- Published by Springer Nature in Acta Veterinaria Scandinavica
- Vol. 52 (1) , 52
Abstract
Background: Porcine contagious pleuropneumonia (PCP) is a highly contagious disease that is caused byActinobacillus pleuropneumoniae(APP) and characterized by severe fibrinous necrotizing hemorrhagic pleuropneumonia, which is a severe threat to the swine industry. In addition to APP RTX-toxins I (ApxI), APP RTX-toxin II (ApxII), APP RTX-toxin III (ApxIII) and Outer membrane protein (OMP), there may be other useful antigens that can contribute to protection. In the development of an efficacious vaccine against APP, the immunogenicities of multicomponent recombinant subunit vaccines were evaluated.Methods: Six major virulent factor genes of APP, i.e.,apxI,apxII,apxIII, APP RTX-toxins IV (apxIV),ompand type 4 fimbrial structural (apfa) were expressed. BALB/c mice were immunized with recombinant ApxI ( rApxI), recombinant ApxII (rApxII), recombinant ApxIII (rApxIII) and recombinant OMP (rOMP) (Group I); rApxI, rApxII, rApxIII, recombinant ApxIV (rApxIV), recombinant Apfa (rApfa) and rOMP (Group II); APP serotype 1 (APP1) inactivated vaccine (Group III); or phosphate-buffered saline (PBS) (Control group), respectively. After the first immunization, mice were subjected to two booster immunizations at 2-week intervals, followed by challenge with APP1 Shope 4074 and APP2 S1536.Results: The efficacy of the multicomponent recombinant subunit vaccines was evaluated on the basis of antibody titers, survival rates, lung lesions and indirect immunofluorescence (IIF) detection of APP. The antibody level of Group I was significantly higher than those of the other three groups (P< 0.05). The survival rate of Group I was higher than that of Groups II and III (P< 0.05) and the control (P< 0.01). Compared with the other three groups, the lungs of Group I did not exhibit obvious hemorrhage or necrosis, and only showed weak and scattered fluorescent dots by IIF detection.Conclusion: The result indicates that the multicomponent recombinant subunit vaccine composed of rApxI, rApxII, rApxIII and rOMP can provide effective cross-protection against homologous and heterologous APP challenge.Keywords
This publication has 27 references indexed in Scilit:
- Genetic Characterization and Immunogenicity of Coli Surface Antigen 4 from Enterotoxigenic Escherichia coli when It Is Expressed in a Shigella Live-Vector StrainInfection and Immunity, 2003
- Evaluation of Cholera Vaccines Formulated with Toxin-Coregulated Pilin Peptide Plus Polymer Adjuvant in MiceInfection and Immunity, 2001
- Immunization with Recombinant Opc Outer Membrane Protein from Neisseria meningitidis : Influence of Sequence Variation and Levels of Expression on the Bactericidal Immune Response against MeningococciInfection and Immunity, 2001
- Identification of type 4 fimbriae inActinobacillus pleuropneumoniaeFEMS Microbiology Letters, 2000
- Bacterial pili: molecular mechanisms of pathogenesisCurrent Opinion in Microbiology, 2000
- Pathogenic and vaccine significance of toxin-coregulated pili of Vibrio cholerae El TorJournal of Biotechnology, 1999
- Protective Efficacy of an Affinity-Purified Hemolysin Vaccine against Experimental Swine Pleuropneumonia.Journal of Veterinary Medical Science, 1997
- Protection of mice and swine against infection with Actinobacillus pleuropneumoniae by vaccinationVeterinary Microbiology, 1994
- Actinobacillus pleuropneumoniae RTX-toxins: uniform designation of haemolysins, cytolysins, pleurotoxin and their genesJournal of General Microbiology, 1993
- Protective efficacy of conjugate vaccines against experimental challenge with porcine Actinobacillus pleuropneumoniaeVeterinary Immunology and Immunopathology, 1992